FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Sarig Yaniv Zion
2. Issuer Name and Ticker or Trading Symbol

Aterian, Inc. [ ATER ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
See Remarks
(Last)          (First)          (Middle)

C/O ATERIAN, INC., 37 E 18TH STREET, 7TH FLOOR
3. Date of Earliest Transaction (MM/DD/YYYY)

3/10/2021
(Street)

NEW YORK, NY 10003
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

3/15/2021 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3/10/2021  S(1)  5211 D$31.6644 (2)254615 D  
Common Stock 3/10/2021  S(1)  636 D$33.1314 (3)253979 D  
Common Stock 3/10/2021  S(1)  3563 D$33.9627 (4)250416 D  
Common Stock 3/10/2021  S(1)  2353 D$35.1265 (5)248063 D  
Common Stock 3/10/2021  S(1)  4123 D$36.1631 (6)243940 D  
Common Stock 3/10/2021  S(1)  2970 D$37.1642 (7)240970 D  
Common Stock 3/10/2021  S(1)  638 D$37.9746 (8)240332 D  
Common Stock 3/11/2021  M  282051 A$9.72 522383 D  
Common Stock 3/11/2021  S(1)  254860 D$31.808 (9)267523 D  
Common Stock 3/11/2021  S(1)  13114 D$32.895 (10)254409 D  
Common Stock 3/11/2021  S(1)  6440 D$33.7992 (11)247969 D  
Common Stock 3/11/2021  S(1)  8251 D$34.6034 (12)239718 D (13) 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy) $9.72 3/11/2021  M     282051   (14)12/28/2028 Common Stock 282051 $0.00 0 D  

Explanation of Responses:
(1) Shares were either: (a) automatically sold by the Reporting Person on a non-discretionary basis solely to satisfy the Reporting Person's tax withholding obligations upon the previously scheduled vesting of restricted stock awards held by the Reporting Person for which the March 10, 2021 vesting date was approved on December 14, 2020, or (b) sold by the Reporting Person solely to satisfy the Reporting Person's tax withholding obligations upon the previously scheduled vesting of restricted stock awards owned by the Sarig-Bulow Family Trust for which the March 10, 2021 vesting date was approved on December 14, 2020. Pursuant to the arrangements of the Sarig-Bulow Family Trust, Mr. Sarig does not beneficially own any of the securities owned by the Sarig-Bulow Family Trust.
(2) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.51 to $32.45, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(3) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.62 to $33.60, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(4) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.63 to $34.63, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(5) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.64 to $35.63, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(6) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.69 to $36.68, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(7) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.71 to $37.71, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(8) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.72 to $38.16, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(9) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.445 to $32.445, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(10) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.45 to $33.45, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(11) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.53 to $34.52, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(12) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.60 to $34.7399, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(13) 776,315 shares held of record by the Sarig-Bulow Family Trust previously reported as indirect ownership by the Reporting Person are not being reported on this Form 4 and will not be reported on future Form 4's by the Reporting Person because the Reporting Person does not beneficially own such shares pursuant to the arrangements of the Trust.
(14) Pursuant to the initial terms of the option, 1/3rd of the number of shares subject to the option vested on October 11, 2019 and 1/36th of the number of shares subject to the option would vest following each one month period thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. The Issuer accelerated the vesting of 60,000 shares subject to the option to March 11, 2021.

Remarks:
President and Chief Executive Officer

This Form 4 is being amended and restated to correct certain footnotes included in the Form 4, as amended (the "Amended Form 4"). The Amended Form 4 inadvertently indicated that the transactions reported therein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Certain of the previously reported transactions were instead either (a) non-discretionary, automatic sales of shares solely to satisfy the Reporting Person's tax withholding obligations upon the previously scheduled vesting of restricted stock awards held by the Reporting Person for which the March 10, 2021 vesting date was approved on December 14, 2020, or (b) sales of shares solely to satisfy the Reporting Person's tax withholding obligations upon the previously scheduled vesting of restricted stock awards owned by the Sarig-Bulow Family Trust for which the March 10, 2021 vesting date was approved on December 14, 2020. Pursuant to the arrangements of the Sarig-Bulow Family Trust, Mr. Sarig does not beneficially own any securities owned by the Sarig-Bulow Family Trust.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Sarig Yaniv Zion
C/O ATERIAN, INC.
37 E 18TH STREET, 7TH FLOOR
NEW YORK, NY 10003
X
See Remarks

Signatures
/s/ Yaniv Sarig12/23/2021
**Signature of Reporting PersonDate

Aterian (NASDAQ:ATER)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Aterian Charts.
Aterian (NASDAQ:ATER)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Aterian Charts.